IL-1 is a pro-inflammatory cytokine that plays an important role in inflammation and host responses to infection. We have previously shown that imbalances in the IL-1 and IL-1R antagonist (IL-1Ra) system cause the development of inflammatory diseases. To explore the role of the IL-1/IL-1Ra system in autoimmune disease, we analyzed myelin oligodendrocyte glycoprotein (MOG)-induced experimental autoimmune encephalomyelitis (EAE) in mice bearing targeted disruptions of the IL-1a, IL-1b, IL-1a and IL-1b (IL-1) or IL-1Ra genes. IL-1a/b double-deficient (IL-1 ÿ/ÿ ) mice exhibited significant resistance to EAE induction with a significant reduction in disease severity, while IL-1a ÿ/ÿ or IL-1b ÿ/ÿ mice developed EAE in a manner similar to wild-type mice. IL-1Ra ÿ/ÿ mice also developed MOG-induced EAE normally with pertussis toxin (PTx) administration. In contrast to wild-type mice, however, these mice were highly susceptible to EAE induction in the absence of PTx administration. We found that both IFN-c and IL-17 production and proliferation were reduced in IL-1 ÿ/ÿ T cells upon stimulation with MOG, while IFN-c, IL-17 and tumor necrosis factor-a production and proliferation were enhanced in IL-1Ra ÿ/ÿ T cells. These observations suggest that the IL-1/IL-1Ra system is crucial for auto-antigenspecific T cell induction and contributes to the development of EAE.
Introduction
Multiple sclerosis (MS) is a chronic inflammatory disease associated with the demyelination of the central nervous system (CNS). Approximately, one million individuals in the world are afflicted by MS (1) . Although significant progress has been made elucidating the causes of MS and improving patient outcomes over the past decade (2) , definitive therapies either reducing the number of attacks or slowing the progression of disease are not yet available.
Experimental autoimmune encephalomyelitis (EAE) is regarded as an animal model mimicking several aspects of the pathogenesis of human MS, which is clinically characterized by paralysis and lethargy (3) . Immunization with self-neuronal antigens, such as MBP, myelin-associated glycoprotein, proteolipid protein or myelin oligodendrocyte glycoprotein (MOG) (3, 4) , results in inflammation within the CNS primarily mediated by CD4 + T h 1 cells (1, 2). Systemic or local induction of cytokines is critical in the initiation, enhancement or perpetuation of CNS disease (5) . T h 1 cell-derived IFN-c, which contributes to the etiology of a wide range of diseases, is markedly elevated within the CNS during EAE. IFN-c-deficient and IFN-cR ÿ/ÿ mice, however, remain highly susceptible to EAE (6) (7) (8) (9) . In fact, the overexpression of IFN-c in the CNS ameliorated the severity of EAE (10) . Tumor necrosis factor (TNF)a, a potent pro-inflammatory cytokine, is produced by a variety of cell types, including T h 1 cells. Mice over-expressing TNFa within the CNS exhibit neuronal demyelination (11, 12) , while the development of EAE in TNFa ÿ/ÿ mice is partially suppressed (13, 14) . Other group reported, however, that in TNFa ÿ/ÿ mice, the course of EAE was exacerbated by the abnormal regression and expansion of myelin-specific T cells (15) . Clinically, anti-TNF therapy resulted in more severe MS (16) . Thus, the contribution of pro-inflammatory cytokines, such as IFN-c and TNFa, cannot fully explain the precise molecular mechanisms underlying EAE development.
IL-1 is produced by a variety of cells, including monocytes/ macrophages, epithelial and endothelial cells and glial cells (17) . Through the up-regulation of intracellular adhesion molecule-1 and vascular cell adhesion molecule-1 expression, this cytokine plays a crucial role in leukocyte extravasation into inflammatory sites (18) . Dysregulation of IL-1 function leads to autoimmune and abnormal immune responses, such as arthritis and aortitis in mouse models (19, 20) . Furthermore, exogenous IL-1 administration exacerbated the course of EAE, while administration of soluble IL-1R type-I (IL-1RI) or IL-1R antagonist (IL-1Ra) significantly suppressed EAE in Lewis rats (21, 22) . Consistent with these observations, mice deficient in IL-1RI or IL-1R-associated kinase 1, which is involved in IL-1-mediated signal transduction, fail to develop inflammatory lesions or any evidence of EAE (23) . These observations suggest that IL-1 may initiate or promote local and/or systemic inflammation during EAE pathogenesis. In vitro, IL-1 can augment the activation of encephalitogenic T lymphocytes, contributing to the development of EAE induced by adoptive transfer (24) . Thus, IL-1 likely contributes to the activation of auto-antigen-specific immune cells, including T cells. Indeed, IL-1 can influence antigen-specific T cell activation directly (25) or indirectly via modulation of dendritic cell (DC) function (26) . The importance of IL-1 in DC function, including migration, activation and acquisition of T h 1-inducing ability, has been demonstrated previously (27, 28) . The precise effect of IL-1 on DCs and/or T cells during the development of EAE, however, has yet to be elucidated.
In this report, we investigate the contribution of IL-1 to the development of EAE using IL-1 ÿ/ÿ and IL-1Ra ÿ/ÿ mice. We determined that IL-1 is responsible for the induction of autoreactive T cells. Our data provide evidence that the IL-1/ IL-1Ra system is critical for the development of CNS autoimmune disease by modulating T cell-mediated immunity.
Methods

Mice
IL-1a
) and IL-1Ra ÿ/ÿ mice were generated as described (29) . Mice were backcrossed to the C57BL/6 strain mice for eight generations. C57BL/6 mice (wild-type mice) were purchased from Clea (Tokyo, Japan). Age-and gender-matched wild-type mice were used as controls in each experiment. Mice were kept under specific pathogen-free conditions in an environmentally controlled clean room at the Center for Experimental Medicine, Institute of Medical Science, University of Tokyo. Animals were housed in an ambient temperature of 24°C on a daily cycle of 12 h of light and darkness (8:00 a.m. to 8:00 p.m.). All the experiments were performed according to the institutional ethical guidelines for animal experimentation.
MOG peptide
MOG 35-55 (MEVGWYRSPFSRVVHLYRNGK), corresponding to the murine sequence, was synthesized on a peptide synthesizer using fluorenylmethoxycarbonyl chemistry and purified by HPLC by Ohmi (Institute of Medical Science, University of Tokyo, Japan).
Induction and evaluation of EAE
Eight-to twelve-week-old mice were subcutaneously immunized with 100 lg MOG 35-55 emulsified in CFA (1 : 1) supplemented with 400 lg Mycobacterium tuberculosis H37RA (DIFCO Lab., Detroit, MI, USA) in both flanks. Pertussis toxin (PTx) (500 ng) (Alexis Corp., San Diego, CA, USA) was injected intravenously into animals on the day of immunization as well as 2 days later.
Mice were inspected daily for the clinical signs of EAE for up to 30 days after immunization. Scores were determined on a scale of 0-5: 0, no disease; 1, limp tail; 2, hind limb weakness; 3, hind limb paralysis; 4, hind and fore limb paralysis and 5, moribund state. The mean clinical score was calculated by averaging the score of all of the mice in each group, including animals that did not develop EAE.
Titer for anti-MOG antibodies in serum
Detection of anti-MOG 35-55 antibodies was performed as described (25) with the following modifications. Briefly, MOG 35-55 peptide (0.5 lg per 96 well) was coated onto 96-well plates and incubated at 4°C overnight. After substantial washing and blocking, diluted sera (30 ll per well) were added to the wells for 2 h at room temperature. A series of serum dilutions were examined in preliminary experiments. After washing, alkaline phosphatase-conjugated goat antimouse Igs (Zymed, San Francisco, CA, USA) were added for 1 h at room temperature, followed by incubation in p-nitrophenyl phosphate substrate (Sigma-Aldrich, St Louis, MO, USA) as the substrate. The anti-MOG antibody titer is given as an OD 415 value. Samples were measured in duplicate.
T cell and DC purification and proliferation assay Mice were immunized subcutaneously with 100 lg MOG 35-55 emulsified CFA (1 : 1) with or without PTx. Ten days later, T cells were prepared from multiple lymph nodes (LNs) (axillary, inguinal, branchial, cervical and poplitial). Cells were washed, treated with anti-mouse Thy1.2 magnetic beads (Miltenyi Biotec, Bergisch Gladbach, Germany) and passed through a MACS Ò column to collect Thy1.2 + T cells. DCs were prepared from the spleen. Spleens were collected, minced and digested with 1 mg ml ÿ1 collagenase (SigmaAldrich) and 1 mg ml ÿ1 DNase I (Sigma-Aldrich) in HBSS for 30 min at 37°C. Following the addition of EDTA (20 mM final concentration), cells were incubated for 5 min at room temperature, passed through a 70-lm nylon mesh, layered over RPMI 1640-10% FCS-14.5% metrizamide (Cedarlane Labs., Ontario, Canada) and centrifuged at room temperature for 30 min at 500 3 g. The low buoyant density cells at the interface were collected and washed twice. Cells were then treated with anti-mouse CD11c magnetic beads (Miltenyi Biotec) and passed through a MACS Ò column. The positively selected fraction was collected, washed and re-suspended for use.
Purified 
ELISA of cytokine levels
The levels of IL-4, IL-17 and TNFa were measured as described (30, 31) . IFN-c levels were measured with OptEIAÒ Set mouse IFN-c kit (BD PharMingen). All assays were done in duplicate.
Statistical analysis
All values were calculated as the average 6 SD. Comparisons were made using the Student's t-test, one-way analysis of variance (ANOVA), Fisher's protected least significant difference test and Mann-Whitney's U-test. Differences among the three groups were tested by Kruskal-Wallis one-way ANOVA.
Results
IL-1
ÿ/ÿ mice are resistant to EAE
To examine the role of the IL-1/IL-1Ra system in the development of EAE, we immunized C57BL/6 wild-type, IL-1
and IL-1RI ÿ/ÿ mice with MOG 35-55 emulsified in CFA. Following the injection of PTx on days 0 and 2, the clinical signs of EAE were monitored daily and scored as described in Methods. IL-1RI ÿ/ÿ mice are known to demonstrate resistance to the development of EAE (23) , suggesting that IL-1 is involved in EAE pathogenesis. We confirmed that IL-1 ÿ/ÿ mice exhibit significant resistance to EAE and that IL-1RI
ÿ/ÿ mice demonstrate a reduction in disease severity (Fig. 1A and data not shown) (23) . The onset of EAE in IL-1 ÿ/ÿ mice was also delayed from that of wild-type mice (Table 1 ). In contrast, mice deficient in either IL-1a or IL-1b developed EAE with a comparable severity and time course to wild-type mice (Fig. 1B) . The incidence of disease, day of onset and maximal clinical score were not significantly different between wildtype, IL-1a ÿ/ÿ and IL-1b ÿ/ÿ mice ( Table 1 ). All genotypes mice exhibited >90% disease incidence. These observations suggest that, while IL-1 plays a principal role in the development of EAE, the presence of either IL-1a or IL-1b alone is sufficient to initiate development of the disease.
Development of EAE is exacerbated in IL-1Ra
ÿ/ÿ mice without PTx administration
We immunized IL-1Ra
ÿ/ÿ mice with MOG 35-55 emulsified in CFA. After an injection of PTx on days 0 and 2, IL-1Ra ÿ/ÿ mice developed EAE that was comparable in time of onset and severity to the EAE course observed in wild-type mice ( Fig. 2A and Table 1 ). PTx is routinely used to facilitate the induction of experimental autoimmune diseases in animals. Previous reports using IL-10 ÿ/ÿ and TNFa ÿ/ÿ mice suggested that coadministration of PTx veiled the effects of cytokines as an inflammatory factor in EAE (15, 32, 33) . Therefore, to address the contribution of IL-1Ra to EAE without the complications of PTx co-administration, we examined the susceptibility of wildtype and IL-1Ra ÿ/ÿ mice to EAE in the absence of PTx. The severity of EAE was reduced in wild-type mice that were not treated with PTx (Fig. 2B) . IL-1Ra ÿ/ÿ mice, however, developed severe EAE in both the absence and presence of PTx (Fig. 2B) . Without PTx, IL-1Ra ÿ/ÿ mice developed more severe EAE at earlier time points than wild-type mice (Table 1) . These results indicate that dysfunction of IL-1 signaling mediated by IL-1Ra deficiency contributes to EAE induction in the absence of PTx. In wild-type mice, PTx may be necessary to overcome the function of IL-1 in EAE induction. ÿ/ÿ (filled squares, n ¼ 9) and IL-1b ÿ/ÿ (filled triangles, n ¼ 7) mice. The data indicate the averages of each group. Statistical significances were determined by Mann-Whitney's U-test (A) and Kruskal-Wallis one-way ANOVA (B). *P < 0.05 versus wild-type mice.
T h 1-type antibody production against MOG 35-55 is increased in sera of IL-1Ra ÿ/ÿ mice Auto-antigen-specific Igs were detected in the sera of mice with EAE. At 37 days after immunization with MOG 35-55, blood samples were collected from mice for the measurement of MOG-specific auto-antibody levels in the sera. The levels of MOG-specific IgG and IgM classes and the IgG1 subclass in sera, as well as those of IgG2b and IgG3 (data not shown), were comparable among IL-1 ÿ/ÿ and wild-type mice given PTx and among IL-1Ra ÿ/ÿ and wild-type mice in the absence of PTx co-administration ( Fig. 3A and B) . In contrast, the levels of MOG-specific IgG2a, whose production depends on T h 1 cytokines, were significantly increased in sera from IL-1Ra ÿ/ÿ mice in comparison with those from wild-type and IL-1 ÿ/ÿ mice ( Fig. 3A and B) . These results suggest that IL-1 signaling promotes the polarization of T h 1 immune responses toward the production of high levels of auto-antigen-specific IgG2a, as seen in IL-1Ra ÿ/ÿ mice during the development of EAE.
IL-1 is involved in auto-antigen-specific T cell activation during EAE
EAE is considered to be a T cell-mediated autoimmune disease model (3). Abnormal EAE induction in IL-1 ÿ/ÿ and IL-1Ra ÿ/ÿ mice may be due to abnormal control of MOGspecific effector T cells. DCs also play a significant role in (auto)immune responses through the induction of T h 1 cell activation (26) . In the EAE animal model, we examined if dysfunction of the IL-1/IL-1Ra system affected T cell or DC function using IL-1 ÿ/ÿ and IL-1Ra ÿ/ÿ mice. We examined in vitro the activation of T cells derived from wild-type, IL-1 DCs ( Fig. 4A and B) , suggesting that IL-1 or IL-1Ra deficiency ÿ/ÿ 9/9 (1) 9.7 6 0.7* 2.9 6 0.6* EAE was induced and scored as described in Methods. Incidence data represent the number of mice. *P < 0.01 versus wild-type mice of each experiment (by Student's t-test or one-way ANOVA). of DCs did not result in any defects in antigen presentation or cytokine production that would influence the induction of MOG-specific T cell recall responses in vitro. Interestingly, the proliferative responses of MOG-specific IL-1Ra ÿ/ÿ T cells were significantly hyperactive following co-cultured with either wildtype (Fig. 4D) or IL-1Ra ÿ/ÿ (data not shown) DCs in comparison with wild-type T cells. In contrast, the responses of IL-1 ÿ/ÿ T cells after co-culture with either wild-type (Fig. 4C ) or IL-1 ÿ/ÿ (data not shown) DCs were profoundly impaired, despite comparable non-specific proliferative responses of T cells against mitogenic stimuli Con A 1 lg ml ÿ1 ) (Fig. 4) . These results indicate that intrinsic IL-1 is responsible for the activation of auto-antigen-specific T cells during the priming process in vivo.
T cells from IL-1Ra
ÿ/ÿ mice produce high levels of pro-inflammatory cytokines We measured cytokine production by MOG-specific T cells by assaying the supernatants of proliferative response cultures. The levels of IFN-c and TNFa in supernatants from wild-type T cells co-cultured with either IL-1 ÿ/ÿ or IL-1Ra ÿ/ÿ DCs were similar to those cultured with wild-type DCs. In contrast, the levels of IFN-c and IL-17, but not TNFa, in the supernatants of IL-1 ÿ/ÿ T cells co-cultures with wild-type DCs was reduced from the levels seen in wild-type T cells co-cultures with wildtype DCs (Fig. 5A and data not shown) . In correlation with MOG-specific T cell proliferative responses, IFN-c, IL-17 and TNFa levels measured in the supernatants of IL-1Ra ÿ/ÿ T cells co-cultures with wild-type or IL-1Ra ÿ/ÿ DCs were significantly increased in comparison with those from wild-type or IL-1 ÿ/ÿ T cells co-cultured with wild-type DCs (Fig. 5B and data not  shown) . The levels of IL-4, a T h 2-skewing cytokine, were below the limits of detection in the supernatants from any of the culture conditions (data not shown). These results suggest that excess IL-1 signaling breaks tolerance for auto-antigens in peripheral lymphoid tissues, resulting in hyperresponsive effector T cell activation and auto-antigen-specific T cell proliferation and inflammatory cytokine production as seen in IL-1Ra ÿ/ÿ mice during EAE pathogenesis.
Discussion
Using IL-1a ÿ/ÿ , IL-1b ÿ/ÿ , IL-1 ÿ/ÿ and IL-1Ra ÿ/ÿ mice, we demonstrate that IL-1 is responsible for the development of EAE. Either IL-1a or IL-1b alone was sufficient to induce EAE; excess IL-1 signaling resulting from the lack of IL-1Ra augmented EAE severity in the absence of PTx injection. These findings suggested that the adjuvant effect of PTx exerts a related function as IL-1 in the induction of EAE. We clearly demonstrated that, while IL-1 controls optimal antigenspecific T cell activation, dysfunction of the IL-1/IL-1Ra system leads to excess T cell activation by breaking peripheral tolerance for auto-antigens during the pathogenesis of EAE.
In a series of inflammatory response models, we have previously shown that antigen-presenting cell (APC)-derived IL-1 was required for (auto)antigen-specific T cell activation. We previously showed that IL-1 plays an important role in the interaction between T cells and APCs in priming process through inducing CD40L (CD154) and OX40 (CD134) on T cells (25) . CD40L and OX40 expressions were enhanced in T cells stimulated with antigen-bearing IL-1Ra ÿ/ÿ APCs compared with wild-type APCs (25) . Thus, upon interaction with antigens, APCs produce IL-1, and IL-1 activates T cells, resulting in the induction of CD40L (34, 35) . Then, CD40L-CD40 interaction activates APCs to produce TNFa (34) . This TNFa induces OX40 on T cells (36) , that leads to enhancement of cytokine production, especially IL-17 (37) . With these mechanisms, APCs-derived IL-1 contributes to the development of allergic and/or autoimmune diseases in mice (28, 36, 38) . IL-1RI
ÿ/ÿ DCs demonstrate impaired cytokine production, leading to insufficient CD4 + T cell activation (26) . Thus, IL-1 can modulate T cell function both directly and indirectly by influencing DC activation. These findings suggest that IL-1 may play a role in the induction and/or activation of autoreactive T cells in EAE. Despite comparable non-specific T cell proliferation upon stimulation with mitogen Con A among wild-type, IL-1 ÿ/ÿ and IL-1Ra ÿ/ÿ mice ( Fig. 4C and D) , the proliferation of MOG-specific IL-1 ÿ/ÿ T cells co-cultured with wild-type DCs, which can produce IL-1, was markedly impaired. The proliferation of IL-1Ra ÿ/ÿ T cells co-cultured with wild-type DCs, which could produce IL-1Ra, was greatly enhanced (Fig. 4C and D) . The proliferation of MOG-specific wild-type T cells co-cultured with IL-1 ÿ/ÿ DCs was similar to that observed with wild-type DCs (Fig. 4A) , indicating that DCderived IL-1 is not essential for the activation of MOG-specific ÿ/ÿ mice exhibited more severe MOGinduced EAE in the absence of PTx injection than wild-type mice. Similarly, the development of EAE in TNFa ÿ/ÿ mice was completely suppressed in the presence of low doses of PTx, although susceptibility to the disease in TNFa ÿ/ÿ mice was normal at high doses of PTx (33) . PTx is widely used to enhance T h 1-mediated organ-specific autoimmune disease through inhibition of the Gi/o protein signaling pathways that negatively regulate IL-12 production (39) and induction of proinflammatory cytokines, MHC class II, CD80, CD86 and CD40 on APCs (40, 41) . These observations imply that PTx exerts a similar function as the pro-inflammatory cytokines IL-1 and TNFa. We, as well as others, previously observed that the function of IL-1 in ovalbumin-induced airway hypersensitivity responses could be substituted for by a potent adjuvant, aluminum potassium sulfate (42, 43) . Therefore, the physiological function of IL-1 (and TNFa) may be masked by the excessive adjuvant-dependent artificial activation of the immune system observed in MOG-EAE with PTx injection and ovalbumin-induced airway hypersensitivity responses with aluminum potassium sulfate.
IFN-c, TNFa and IL-17, T cell-derived inflammatory cytokines, play critical roles in multiple pathological inflammatory responses. TNFa has a similar biological activity to IL-1 as a potent pro-inflammatory cytokine. As seen in studies using TNFa ÿ/ÿ mice, TNFa is also involved in the development of EAE (13, 14) . Interestingly, TNFa production is normal in IL-1 ÿ/ÿ mice after MOG/CFA immunization (Fig. 5A) , despite the profound suppression of EAE development in IL-1 ÿ/ÿ mice ( Fig. 1 and Table 1 ). In contrast, IL-1Ra ÿ/ÿ mice exhibited elevated TNFa production (Fig. 5B) and exacerbated development of EAE ( Fig. 2 and Table 1 ). Thus, TNFa is not essential for, but contributes to, the development of EAE (15, 23, 44) . Excess TNFa production resulting from excessive : IL-1Ra ÿ/ÿ mice. Data indicate the averages. These data were reproducible in three independent experiments. Statistical significances were determined by one-way ANOVA and Fisher's protected least significant difference test. *P < 0.01 versus wild-type mice.
IL-1 activity may explain the synergistic exacerbation of EAE development in IL-1Ra ÿ/ÿ mice. These results suggest, however, that TNFa alone is not sufficient to induce adequate responses in the absence of IL-1, as observed in IL-1 ÿ/ÿ mice. While IFN-c-producing T h 1 cells are crucial for the induction of autoimmune diseases, IFN-c ÿ/ÿ and/or IFN-cR ÿ/ÿ mice develop autoimmune diseases, such as EAE and collageninduced arthritis (6) (7) (8) (9) 45) . Currently, T cell-derived IL-17, rather than IFN-c, is suspected to be critical in the pathogenesis of EAE. In support of this hypothesis, increased levels of IL-17 were observed in the lesions of MS patients (46) . Otherwise, IL-12 has been well characterized as a potent activator of IFN-c-producing T h 1 cells, while IL-23, a member of the IL-12 family consisting of IL-23 p19 and IL-12 p40, can induce IL-17 production by T cells (47) . IL-23, but not IL-12, is crucial for the development of EAE (48) . As seen with IFN-c ÿ/ÿ and IL-12 ÿ/ÿ mice, IL-12Rb2 ÿ/ÿ mice exhibited exacerbated EAE development and increased IL-17 production (49). IL-12 administration, however, led to the inhibition of IL-17 mRNA expression during EAE pathogenesis (50) . Currently, the contribution of IL-17 to the pathogenesis of EAE was suggested in mice treated with anti-IL-17-neutralizing antibody (51). We : IL-1Ra ÿ/ÿ mice. Data indicate the averages. These data were reproducible in two independent experiments. Statistical significances were determined by one-way ANOVA and Fisher's protected least significant difference test. *P < 0.01 versus wild-type mice.
determined that, in MOG-stimulated T cells, IL-17 production was reduced in IL-1 ÿ/ÿ mice and increased in IL-1Ra ÿ/ÿ mice ( Fig. 5A and B) . Thus, our data suggest that IL-1 plays an important role in the activation of both IFN-c-producing T h 1 and IL-17-producing CD4 + T cells, contributing to the development of EAE.
In conclusion, our findings suggest that dysregulation of the IL-1/IL-1Ra balance leads to the failure of peripheral lymphoid tolerance for self-antigens, resulting in the severe inflammation seen in EAE. These observations may provide a clue to develop new therapeutics against MS.
